Access cutting-edge mucosal melanoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access mucosal melanoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mucosal melanoma treatment provided free
The researchers are doing this study to find out whether the combination of axitinib and nivolumab is an effective and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before. The researchers think that a combination of axitinib and nivolumab may help people with this disease because both drugs target and block proteins that play a role in cancer cell survival and growth. The researchers think the drugs may be more effective if given in combinatio
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this mucosal melanoma clinical trial in New York, NY
If you're searching for mucosal melanoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mucosal melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.